Sign up
Quantellect · Congress · Trade Detail
NYSE: CRLCharles River Laboratories
RepublicanHouse

Jefferson Shreve bought Charles River Laboratories (NYSE: CRL)

Jefferson Shreve (R-IN), a U.S. Representative, has disclosed 2 trades in Charles River Laboratories (CRL) since 2025, 1 purchase and 1 sale, worth an estimated $65K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Jefferson Shreve bought $15,001 - $50,000 of Charles River Laboratories (NYSE: CRL) on May 8, 2025. Since that trade, CRL is up +66.10% against the S&P 500 up +30.58%, an outperformance of +35.52%.

Across these filings, Jefferson Shreve has been a balanced trader of CRL (a buy-to-sell ratio of 1.00). The most recent disclosed CRL transaction shown was dated May 12, 2025. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

CRL trades
2
Disclosed Vol
$65K
Buys
1
50%
Sells
1
50%
Buy / Sell
1.00
ratio
First → Last
2025

Jefferson Shreve's CRL trades vs the price

CRL is up +66.10% since Jefferson Shreve bought on May 8, 2025, versus +30.58% for the S&P 500.

Performance since this trade

Price change since trade
+66.10%
S&P 500 change since trade
+30.58%
Outperformance vs S&P 500
+35.52%

All Jefferson Shreve CRL trades

TradedTypeSizeReturnEst. profit
May 12, 2025SELL$143.08+64.10%
May 8, 2025BUY$141.36+66.10%+$21K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Jefferson Shreve & CRL trading FAQ

Is it legal for Jefferson Shreve to trade Charles River Laboratories (CRL) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Charles River Laboratories (CRL), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Jefferson Shreve buy CRL?

Jefferson Shreve disclosed a purchase of $15,001 - $50,000 of Charles River Laboratories (CRL) on May 8, 2025, according to public STOCK Act filings.

How has CRL performed since Jefferson Shreve's trade?

Since Jefferson Shreve bought CRL on May 8, 2025, the stock is up +66.10%, versus +30.58% for the S&P 500 over the same period, an outperformance of +35.52%.

How many times has Jefferson Shreve traded CRL?

Jefferson Shreve has disclosed 2 CRL trades since 2025 (1 purchase and 1 sale). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional CRL trades?

Quantellect tracks every disclosed congressional trade in Charles River Laboratories (CRL) on the Charles River Laboratories congressional trading page, which aggregates filings across all members of Congress.

Jefferson Shreve's CRL tradesAll congressional filings for Charles River LaboratoriesJefferson Shreve's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.